← Back
other
Transcend Therapeutics
Last discussed Nov 11, 2026
A biotech company commercializing methylone as a therapeutic compound, acquired for its work separating the drug treatment from psychotherapy in clinical trials.
Recently discussed in
Q&A with Tim — How to Get Unstuck, Resilience in Hard Times, Tools for Brain Health, and More
Tim Ferriss · Nov 11, 2026
Dr. Andrew Huberman — Peptides, Performance, and Protocols
Andrew Huberman · Jul 22, 2026
What creators say
Tim Ferriss
mentioned
"And Transcend Therapeutics, which was co-founded by Kevin Ryan. I think that stands a chance of reaching millions of people because it is easier to slot into the pre-existing health care system."
More from Tim Ferriss →
Andrew Huberman
mentioned
Praised: Separated drug treatment from psychotherapy component, leading to successful ...
vs: Compared to MAPS protocol for MDMA which had regulatory issues with the combi...
"People can check out Transcend Therapeutics. It just got acquired, or at least the majority was purchased. They have been commercializing methylone, which is a very, very interesting compound — it's like the shorter acting, softer cousin of MDMA, ..."
More from Andrew Huberman →Keep exploring
Topics
About this data
- ✓50,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out
Get an email when a new creator recommends it